MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cidara Therapeutics Company Profile (NASDAQ:CDTX)

Consensus Ratings for Cidara Therapeutics (NASDAQ:CDTX) (?)
Ratings Breakdown: 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $21.25 (84.94% upside)

Analysts' Ratings History for Cidara Therapeutics (NASDAQ:CDTX)
Show:
DateFirmActionRatingPrice TargetActions
5/14/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2016WedbushReiterated RatingOutperform$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2015Needham & Company LLCReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2015WBB SecuritiesUpgradeSell -> Hold$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2015BTIG ResearchInitiated CoverageBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha